Apyx Medical (FRA:BOV) COGS-to-Revenue : 0.42 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Apyx Medical COGS-to-Revenue?

Apyx Medical's Cost of Goods Sold for the three months ended in Mar. 2024 was €3.95 Mil. Its Revenue for the three months ended in Mar. 2024 was €9.42 Mil.

Apyx Medical's COGS to Revenue for the three months ended in Mar. 2024 was 0.42.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Apyx Medical's Gross Margin % for the three months ended in Mar. 2024 was 58.08%.

Apyx Medical COGS-to-Revenue Historical Data

The historical data trend for Apyx Medical's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apyx Medical COGS-to-Revenue Chart

Apyx Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.32

0.37

0.31

0.35

0.36

Apyx Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.38	0.32	0.33	0.39	0.42

Apyx Medical COGS-to-Revenue Calculation

Apyx Medical's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	17.047	/	48.004
	=	0.36

Apyx Medical's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	3.951	/	9.424
	=	0.42

Apyx Medical (FRA:BOV) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Apyx Medical's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	3.951 / 9.424
	=	58.08 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Apyx Medical COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Apyx Medical's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Apyx Medical (FRA:BOV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Apyx Medical Corp (FRA:BOV) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

APYX:USA

Address

5115 Ulmerton Road, Clearwater, FL, USA, 33760

Website

https://apyxmedical.com

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Apyx Medical (FRA:BOV) Headlines

No Headlines